©The Author(s) 2025.
World J Gastrointest Surg. Oct 27, 2025; 17(10): 108239
Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.108239
Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.108239
Figure 5 Effects of compound spleen-tonifying composition and extract parts on colon inflammation in dextran sulfate sodium-induced rats.
A: Tumor necrosis factor-α content; B: Interleukin-6 content; C: Interleukin-1β content; n = 8. aP < 0.05, dextran sulfate sodium (DSS) group vs control group; bP < 0.05, positive group vs DSS group; cP < 0.05, compound spleen-tonifying composition (CSTC) high dose group vs DSS group; dP < 0.05, CSTC medium dose group vs DSS group. TNF-α: Tumor necrosis factor-α; IL-6: Interleukin-6; IL-1β: Interleukin-1β; DSS: Dextran sulfate sodium; CSTC-H: Compound spleen-tonifying composition high dose; CSTC-M: Compound spleen-tonifying composition medium dose; CSTC-L: Compound spleen-tonifying composition low dose.
- Citation: Zhao WC, Zhao QL, Zhang Y, Zhao N, Tian JQ, Wu YY, Zhang W. Compound spleen-tonifying composition alleviates dextran sulfate sodium-induced ulcerative colitis in rats. World J Gastrointest Surg 2025; 17(10): 108239
- URL: https://www.wjgnet.com/1948-9366/full/v17/i10/108239.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i10.108239